Estradiol with dydrogesterone - Menopausal disorders
You are here : Home > Formulary Search > Estradiol with dydrogesterone - Menopausal disorders
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
Femoston tablets - 1st line for women requiring sequential combined therapy.
Status 2
Green
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
Femoston Conti - 1st line for women requiring continuous combined therapy.
Documentation
PAD Profile
ChemicalSubstance :
Estradiol with dydrogesterone
Indication :
Menopausal disorders
Group Name :
Keywords :
hormone replacement therapy, HRT, menopause, sequential combined therapy, continuous combined therapy, menopausal symptoms
Brand Names Include :
Femoston, Femoston Conti
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Estradiol with dydrogesterone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Conjugated oestrogens with medroxyprogesterone
- Drospirenone
- Estradiol
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with norethisterone
- Estradiol with progesterone
- Ethinylestradiol
- Gabapentin
- Levonorgestrel
- Medroxyprogesterone acetate
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine
Committee Recommendations (1)
The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations: